Sort
21,453 grants matching “tuberculosis”
Regulation of T cell homeostasis and memory
$547,166Linda Mac Pherson Bradley · Univ Of Massachusetts Med Sch Worcester · P01 · FY2013 · AI
Administrative Core and Data Management Center
$547,117Henry M Blumberg · Emory University · U19 · FY2016 · AI
Flow cytometer Cell Sorter for Biosafety Level-3 Facility
$547,000Ankita Garg · University Of Georgia · S10 · FY2021 · OD
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
$547,000Robert Michael Angelo · Stanford University · UH3 · FY2021 · CA
Microbiome in TB treatment response and disease resolution
$546,981Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2021 · AI
Pre-Exposure Prophylaxis Against Francisella tularensis
$546,688Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2013 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY FUNDING ANNOUNCEMENT
$546,581Connie Calisti-Myers · New Jersey State Dept/Health/Senior Srvs · U52 · FY2016 · PS
How does HIV lead to increased susceptibility to tuberculosis?
$546,571David G Russell · Cornell University · R01 · FY2019 · AI
How does HIV lead to increased susceptibility to tuberculosis?
$546,571David G Russell · Cornell University · R01 · FY2017 · AI
The Utility of Interferon-Gamma Release Assays in TB-HIV co-infected Children
$546,560Anna M Mandalakas · Case Western Reserve University · R01 · FY2009 · AI
Improving specificity of HPV Screen-and-Treat in South Africa
$546,487Louise Kuhn · Columbia University Health Sciences · UH3 · FY2016 · CA
Effectiveness of the TB Contact Priority Model
$546,475Lynn B Gerald · University Of Alabama At Birmingham · R01 · FY2007 · HL
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$546,375Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2023 · AI
Unintended and Intended Implications of HIV Cure: A Social and Ethical Analysis
$546,174Joseph David Tucker · Univ Of North Carolina Chapel Hill · R01 · FY2016 · AI
HIV Infection in Drug Users in Two International Sites
$546,115Sherwood L Gorbach · Tufts University Boston · R01 · FY2009 · DA
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 2/2)
$546,078Gabriel Chamie · University Of California, San Francisco · U01 · FY2021 · AA
Interruption of maternal-fetal transmission of HIV
$545,915Joseph M McCune · University Of California, San Francisco · R01 · FY2009 · AI
A Novel Oral Combination Pediatric HIV and TB Vaccine
$545,865Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2010 · DE
Cellular and Bacterial Dynamics in Tuberculosis
$545,842Joel D. Ernst · University Of California, San Francisco · R01 · FY2019 · AI
Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence
$545,825Philip J Goulder · University Of Oxford · U01 · FY2022 · AI
TB Vaccine Candidates Found in Patients' Bodily Fluids and Murine MHC-1 Molecule
$545,562Antonio Campos-Neto · Ada Forsyth Institute, Inc. · R01 · FY2012 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$545,453Leonard Mukasa · Arkansas State Department Of Health · U52 · FY2015 · PS
Spatially mapping and modeling tuberculosis granulomas to define the immunological determinants of infection outcome
$545,386Erin McCaffrey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$545,328Rochelle P Walensky · Massachusetts General Hospital · R01 · FY2013 · AI
Community Transmission of Tuberculosis in Urban Africa
$545,297Christopher C. Whalen · University Of Georgia · R01 · FY2013 · AI